| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/07/2001 | EP0830370B1 N-1-carboxyalkyl derivatives of lsd |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | EP0559769B1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 02/07/2001 | CN1283234A Method for suppressing multiple drug resistant in cancer cells |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/06/2001 | US6184359 Humanized monoclonal antibody which preferentially binds lymphocyte polypeptide; for treatment of toxicity in tumor therapy; for the treatment and prevention of gastrointestinal and viral diseases |
| 02/06/2001 | US6184357 Antibody which binds a preferential polypeptide; for the diagnosis, prevention and treatment of prostate cancer and hyperplasia |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6184206 Administering a compound which dissociates fibrinogen bound to a first site on platelet glycoprotein iib-iiia, by binding to a second interacting site of the platelet glycoprotein, disaggregating the platelet thrombus |
| 02/06/2001 | US6184042 Method for reducing hook effect in an immunoassay |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184022 Membrame matrix enzymatic protein; for use in the diagnosis and of tumors |
| 02/06/2001 | US6184016 Polypeptides having prenylcysteine carboxyl methyltransferase activity or inhibiting activity |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183990 Compounds |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183971 Human betacellulin-specific antibodies and uses thereof |
| 02/06/2001 | US6183962 Nucleotide sequence of cardiovascular system associated protein kinase; antisense agents; recombinant expression vectors; host cells for culture production; diagnosis and treatment of cardiovascular disorders; probes; primers; kits |
| 02/06/2001 | US6183949 HCV peptide antigens and methods for the determination of HCV |
| 02/06/2001 | US6183755 These proteins can be used to produce specific and sensitive diagnostic assay kits. the specific combination of the immunologically active proteins makes precise diagnosis possible. |
| 02/06/2001 | US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183744 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 02/06/2001 | CA2213798C Method for stimulating an immune response |
| 02/06/2001 | CA2163032C Antibody fragments in therapy |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2075974C Totally synthetic affinity reagents |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
| 02/05/2001 | CA2311201A1 Ests and encoded human proteins |
| 02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients |
| 02/01/2001 | WO2001007914A1 Fenretinide increases antibody cellular toxicity |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007627A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/01/2001 | WO2001007613A2 Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007480A2 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 02/01/2001 | WO2001007479A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007472A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007466A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007084A1 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
| 02/01/2001 | WO2001007083A1 Recombinant antibody directed against human sperm antigen |
| 02/01/2001 | WO2001007082A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000061728A3 Human elastase i |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000053756A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000045842A3 Methods for human allografting |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000011035A9 Hiv suppressor factor derived from scrub typhus |
| 02/01/2001 | WO1999066951A8 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 02/01/2001 | WO1999061040A9 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE19935508A1 Producing a glycoprotein product that stimulates tumor necrosis factor alpha production, useful for treating cancer and viral infections, comprises culturing Rhodococcus fascians |
| 02/01/2001 | DE19934458A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2379863A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379802A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2379251A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | CA2379237A1 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | CA2378953A1 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |